Application of Inonotus obliquus polysaccharide components in preventing and controlling chronic pancreatitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for chronic pancreatitis and Inonotus obliquus, which is applied in the field of medicine to achieve the effects of reducing accumulation, reducing synthesis, and slowing down immune metabolism
Inactive Publication Date: 2015-12-16
NORTHEAST AGRICULTURAL UNIVERSITY
View PDF3 Cites 12 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, there is no report on the study of polysaccharides from Inonotus obliquus in slowing down chronic pancreatitis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0034] The extraction, purification and analysis of the polysaccharide component of embodiment 1 Inonotus obliquus
[0035] The sclerotium of Inonotus obliquus was provided by Baikaltai Bioengineering Company, Harbin, China. Glucose (Glu), galactose (Gal), rhamnose (Rha), arabinose (Ara), xylose (Xyl), galacturonic acid (GalUA), purchased from sigma company; derivatization reagent: 1-benzene Base-3-methyl-5-pyrazolone (PMP), with a purity of 99%, was purchased from Across Organics.
[0037] (1) Extraction of Inonotus obliquus polysaccharide components
[0038] The sclerotium of Inonotus obliquus needs to be dried in an oven at 70°C to constant weight, then ground into powder, added with 70% to 80% ethanol by volume, and extracted at room temperature for 24-72 hours to remove impurities in th...
Embodiment 2
[0054] The pharmacological activity evaluation of embodiment 2 Inonotus obliquus polysaccharide components
[0055] (1) Test material:
[0056] The mice used in the experiment were five-week-old Kunming white mice purchased from the Drug Safety Evaluation Center of Heilongjiang University of Traditional Chinese Medicine. Sodium diethyldithiocarbamate was purchased from Jining Huide Chemical Co., Ltd., Qingyi Lidan Granules were purchased from Changchun Yinnuoke Pharmaceutical Co., Ltd., cytokine ELISA kit, amylase and lactate dehydrogenase kit and hydroxyl The proline kit was purchased from Nanjing Jiancheng Technology Co., Ltd., and the polysaccharide component of Inonotus obliquus was the 10th tube of IOP-1 prepared according to the method in Example 1, that is, IOP-1 (10).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses application of Inonotus obliquus polysaccharide components in preventing and controlling chronic pancreatitis and belongs to the technical field of medicaments. The Inonotus obliquus polysaccharide components are applicable to preventing and controlling chronic pancreatitis. The Inonotus obliquus polysaccharide components which are 0.4g / kg of mouse weight are effective in increasing the content of superoxide dismutase in pancreatic glands of mice with chronic pancreatitis and decreasing accumulation of malondialdehyde and meanwhile are capable of reducing IL-1Beta and IFN-Nu in serum, and effective in decreasing the contents of amylase and lactic dehydrogenase and decreasing synthetic hydroxyproline. An application method of Inonotus obliquus polysaccharide components alleviate the condition of chronic pancreatitis in terms of immunity and metabolic regulation; compared with methods such as accumulated heat and dyspepsia conditioning in traditional Chinese medicine and medicated analgesia and surgery in western medicine, the method has the advantages that no toxic or side effect occurs, surgical pain is avoided, a treatment course is short, treatment is safe and convenient, and the effect of preventing and treating chronic pancreatitis in mice is significant.
Description
technical field [0001] The invention relates to a natural edible and medicinal fungus polysaccharide component, in particular to the application of the polysaccharide component of Inonotus obliquus in preventing and treating chronic pancreatitis, and belongs to the technical field of medicine. Background technique [0002] Chronic pancreatitis is a long-standing pancreas inflammation that can change the normal structure of the tissue and the endocrine function. Chronic pancreatitis is characterized by inflammatory cell infiltration, acinar atrophy, granulation tissue formation, irregular fibrosis, and ductal abnormalities, among others (Inui,K.,Yoshino,J.,Miyoshi,H.,Yamamoto,S.,Kobayashi, T., 2013. New developments in diagnosis and non-surgical treatment of chronic pancreatitis. Journal of Gastroenterology and Hepatology. 28, 108–112.). Pancreatic fibrosis is a typical histopathological feature of the pancreas (PhillipsP., 2012. Pancreaticstellate cells and fibrosis, in: Gr...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more